Latest Articles

Publication Date
Gilead Sciences Advances Endometrial Cancer Treatment with New Phase 3 Study - TipRanks

Gilead Sciences Advances Endometrial Cancer Treatment with New Phase 3 Study TipRanks

Published: Sept. 7, 2025, 5:31 p.m.
Belfast woman felt 'crazy' waiting for endometriosis diagnosis - Rayo

Belfast woman felt 'crazy' waiting for endometriosis diagnosis Rayo

Published: Sept. 7, 2025, 7:27 a.m.
Endometrial cancer: new markers for PET imaging - healthcare-in-europe.com

Endometrial cancer: new markers for PET imaging healthcare-in-europe.com

Published: Sept. 7, 2025, 6:23 a.m.
Attribute preferences associated with gonadotropin-releasing hormone agonists/antagonists among women with endometriosis in the United States.

Endometriosis symptoms have multifaceted manifestations, and there are few approved nonsurgical treatment options. Gonadotropin-releasing hormone (GnRH) agonists/antagonists for endometriosis vary on efficacy, safety profile, and out-of-pocket (OOP) cost, among other …

Published: Sept. 7, 2025, midnight
Clinical value of preoperative serum calcium level in predicting deep infiltrative endometriosis among ovarian endometrioma.

To evaluate preoperative serum calcium levels and their association with deep infiltrating endometriosis (DIE) in ovarian endometrioma.

Published: Sept. 7, 2025, midnight
Risk of Abortion and Ectopic Pregnancy in Women with a History of Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study.

Objectives: The purpose of this retrospective cohort study was to ascertain the risk of abortion, ectopic pregnancy and hydatidiform mole development in women with polycystic ovary syndrome (PCOS) using data …

Published: Sept. 7, 2025, midnight
Genmab (CPSE:GMAB) Is Up 10.3% After FDA Breakthrough for Rina-S in Endometrial Cancer – Has The Bull Case Changed? - Yahoo Finance

Genmab (CPSE:GMAB) Is Up 10.3% After FDA Breakthrough for Rina-S in Endometrial Cancer – Has The Bull Case Changed? Yahoo Finance

Published: Sept. 6, 2025, 11:31 a.m.
AbbVie’s Phase 3b Study on Elagolix: A Potential Game-Changer for Endometriosis Treatment? - TipRanks

AbbVie’s Phase 3b Study on Elagolix: A Potential Game-Changer for Endometriosis Treatment? TipRanks

Published: Sept. 6, 2025, 4:33 a.m.
Scientists discover potential cause of painful endometriosis in women — here's what you need to know - yahoo.com

Scientists discover potential cause of painful endometriosis in women — here's what you need to know yahoo.com

Published: Sept. 6, 2025, 4:15 a.m.
A machine learning approach towards endometriosis screening using infrared spectra of urine.

Endometriosis diagnosis is challenging due to non-specific symptoms that overlap with other gynaecological conditions. This study proposes a non-invasive Machine Learning (ML) ‒ based urine test using Attenuated Total Reflection …

Published: Sept. 6, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!